Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags UnitedHealth Group Inc Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Trump fires Fed's Cook, Musk sues Apple and OpenAI, Netflix's theatrical run and more in Morning Squawk
Tags 5 Things to Know Eli Lilly and Co Business
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Eli Lilly and Co US: News Companies
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Nestle SA Pfizer Inc Travel
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Structure Therapeutics Inc Pfizer Inc Business
From CNBC.com News
CNBC's UK Exchange newsletter: The price is REIT
Tags Perella Weinberg Partners Real estate Europe Markets
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Eli Lilly and Co US: News Companies
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Health care industry Biotech and Pharmaceuticals Business News
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Health care industry Biotech and Pharmaceuticals Business News
From CNBC.com News
'Don't quit the market' when it's frothy, says Jim Cramer. Here's why
Tags Figma Inc Business Circle Internet Group Inc
From CNBC.com News
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
Tags Breaking News: Business Business Health care industry
From CNBC.com News
Cramer's Lightning Round: Affirm is a buy
Tags Investment strategy Business S&P 500
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Investment strategy McDonald's Corp Dine Brands Global
From CNBC.com News
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Tags Companies US: News Eli Lilly and Co
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Breaking News: Business Business Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Healthy Returns Amgen Inc Pfizer Inc
From CNBC.com News
5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy
Tags Walt Disney Co Economy Business News
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Marriott International Inc Investment Strategy Stock Picks
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Sanofi SA Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Business Breaking News: Business Business News
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Eli Lilly and Co US: News Bristol/Myers Squibb Co
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Business Breaking News: Business Business News
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Eli Lilly and Co Social issues Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Rocket Lab is a buy
Tags Investment Strategy Stock Picks Eli Lilly and Co
From CNBC.com News
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
Tags Roche Holding AG Biotechnology Sanofi SA
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Business Hims & Hers Health Inc Business News
From CNBC.com News
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags AbbVie Inc Biotechnology Health & Science
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Red Robin Gourmet Burgers Inc APA Corp (US) Brinker International Inc
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Marine Ports and Services US Economy Drug Retail
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Transportation and shipping Home Depot Inc State of Freight
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.